Group 1 - The core viewpoint of the articles emphasizes the resurgence of traditional medicine, particularly ethnic medicine, as a rational choice in the medical system driven by the demand for effective treatments for chronic diseases and complex conditions [1][2] - The "14th Five-Year Plan for the Development of Traditional Chinese Medicine" highlights the need to enhance research on ethnic medicine for major diseases and advantageous conditions, while the WHO's 2025-2034 Traditional Medicine Strategy aims to improve global health coverage [1] - The effectiveness of ethnic medicine is rooted in thousands of years of clinical validation, and modern research methods like evidence-based medicine are bridging the gap between traditional and modern medical understanding [1] Group 2 - Qizheng Tibetan Medicine, established in 1995, prioritizes patient benefits and focuses on clinical needs through research and technological innovation to enhance drug efficacy and safety [2] - The company has developed a comprehensive ecosystem covering the entire industry chain, including medicinal material cultivation, research and development, intelligent manufacturing, marketing, sales, and medical services [2] - On its 30th anniversary, the company aims to double its performance in five years, reach a revenue of 10 billion in ten years, and become a globally influential Tibetan medicine health industry group in thirty years [2]

Core Viewpoint - The letter from the chairman of Qizheng Tibetan Medicine marks the 30th anniversary of the company, highlighting its journey and commitment to the modernization of Tibetan medicine through innovation, inheritance, and integration [1][3]. Group 1: Company Development - Qizheng Tibetan Medicine was established in 1995 and has achieved three significant milestones: being the first company to settle in Tibet for poverty alleviation, listing on the Shenzhen Stock Exchange as the first Tibetan medicine stock, and becoming a leading enterprise in the modernization of Tibetan medicine [1][3]. - The company has maintained a double-digit annual revenue growth over the past 30 years, attributed to its focus on innovation, inheritance, and integration [1][3]. Group 2: Innovation - The company emphasizes the development of effective products, such as pain relief patches and capsules, utilizing modern formulation technologies to enhance stability and convenience [2][4]. - Qizheng has expanded its product range to cover eight therapeutic areas, including respiratory, digestive, cardiovascular, neurological, skin, gynecological, and pediatric treatments [2][4]. Group 3: Inheritance - The company prioritizes the authenticity of its products by establishing connections with contemporary Tibetan medicine masters and supporting the education and development of Tibetan medicine [4]. - Initiatives include the establishment of a traditional Tibetan medicine inheritance center, construction of Tibetan hospitals, and funding for grassroots Tibetan medical clinics [4]. Group 4: Integration - Qizheng promotes Tibetan medicine through evidence-based research, aiming to include its products in national health insurance and essential drug lists, thereby enhancing treatment options for doctors and patients [4]. - The company has developed a comprehensive sales strategy that includes various channels such as tiered medical services, grassroots medical care, retail, B2C, and commercial sales [4].